4
Changes in Ownership
PharmaCyte Biotech, Inc. Filed Acc 0001683168-25-009112
Director gave up 16,875 shares (to pay taxes)
- Director acquired 37,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Abecassis Michael M · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-12 | Grant or award : show line 1 in the form | +37,500 | 39,167 | D | ||
| 2025-12-12 | Shares withheld for taxes : show line 2 in the form | −16,875 | $1.02 | $17,213 | 22,292 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-04-25 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +63,233 | 63,233 | D |
Loading xslF345X05/ownership.xml…